PhRMA general counsel moving to Merck
Executive Summary
Pharmaceutical Research & Manufacturers of America General Counsel Bruce Kuhlik will leave the association May 13 to join Merck as VP and associate general counsel on May 23. Kuhlik has been with PhRMA since October 2002. In addition to providing business and regulatory advice at Merck, he will work on defending the company against litigation related to the withdrawn COX-2 inhibitor Vioxx...